The DOI matches its Crossref record; 121 of the 121 references it cites were found in a registry or an index.
Tumor suppressor p53 and metabolism
Open accessAbstract
p53 plays a key role in tumor suppression. The tumor suppressive function of p53 has long been attributed to its ability to induce apoptosis, cell cycle arrest, and senescence in cells. However, recent studies suggest that other functions of p53 also contribute to its role as a tumor suppressor, such as its function in metabolic regulation. p53 regulates various metabolic pathways to maintain the metabolic homeostasis of cells and adapt cells to stress. In addition, recent studies have also shown that gain-of-function (GOF) mutant p53 proteins drive metabolic reprogramming in cancer cells, contributing to cancer progression. Further understanding of p53 and its GOF mutants in metabolism will provide new opportunities for cancer therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The emerging hallmarks of cancer metabolism
Pavlova, N. N., & Thompson, C. B. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.006 · Cited by 5,926 · cited 2×
“Tumor suppressor p53 Metabolic reprogramming is a hall marker of cancer cells, which plays a pivotal role in cancer progression by providing energy and a wide variety of substrates for biosynthesis to support the rapid proliferation and survival of cancer cells (Cairns et al., 2011; Pavlova and Thompson, 2016; Wolpaw…”
BackgroundRegulation of cancer cell metabolism
Cairns, R. A., Harris, I. S., & Mak, T. W. (2011) · Nature Reviews Cancer · doi:10.1038/nrc2981 · Cited by 4,744 · cited 2×
“Tumor suppressor p53 Metabolic reprogramming is a hall marker of cancer cells, which plays a pivotal role in cancer progression by providing energy and a wide variety of substrates for biosynthesis to support the rapid proliferation and survival of cancer cells (Cairns et al., 2011; Pavlova and Thompson, 2016; Wolpaw…”
BackgroundMice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649
The metabolism of tumors in the body
Warburg, O., Wind, F., & Negelein, E. (1927) · Journal of General Physiology · doi:10.1085/jgp.8.6.519 · Cited by 4,416
Ferroptosis as a p53-mediated activity during tumour suppression
Jiang, L., Kon, N., Li, T., Wang, S.-J., Su, T., Hibshoosh, H., Baer, R., & Gu, W. (2015) · Nature · doi:10.1038/nature14344 · Cited by 3,398 · cited 4×
“p53 was recently reported to induce ferroptosis through its negative regulation of SLC7A11, a component of the cystine/glutamate antiporter (Jiang et al., 2015).”
BackgroundInfluentialMetabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
Ward, P. S., & Thompson, C. B. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.014 · Cited by 3,233
Blinded by the Light: The Growing Complexity of p53
Vousden, K. H., & Prives, C. (2009) · Cell · doi:10.1016/j.cell.2009.04.037 · Cited by 3,163
Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis
Menendez, J. A., & Lupu, R. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2222 · Cited by 2,941 · cited 1×
“Increased de novo lipid synthesis is another important metabolic change in many cancers; whereas most normal tissues preferentially use circulating lipids, many cancer cells display a high rate of de novo lipid synthesis (Menendez and Lupu, 2007; Currie et al., 2013; Rohrig and Schulze, 2016).”
BackgroundVousden, K. H., & Lane, D. P. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2147 · Cited by 2,272
Cellular Fatty Acid Metabolism and Cancer
Currie, E., Schulze, A., Zechner, R., Walther, T. C., & Farese, R. V. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.05.017 · Cited by 2,123 · cited 1×
“Increased de novo lipid synthesis is another important metabolic change in many cancers; whereas most normal tissues preferentially use circulating lipids, many cancer cells display a high rate of de novo lipid synthesis (Menendez and Lupu, 2007; Currie et al., 2013; Rohrig and Schulze, 2016).”
BackgroundGlutaminolysis and transferrin regulate ferroptosis
Gao, M., Monian, P., Quadri, N., Ramasamy, R., & Jiang, X. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.06.011 · Cited by 2,069 · cited 1×
“p53 target GLS2 was reported to be essential for ferroptosis; knockdown of GLS2 greatly abolishes ferroptosis in cells (Gao et al., 2015).”
BackgroundTumor spectrum analysis in p53-mutant mice
Jacks, T., Remington, L., Williams, B. O., Schmitt, E. M., Halachmi, S., Bronson, R. T., & Weinberg, R. A. (1994) · Current Biology · doi:10.1016/s0960-9822(00)00002-6 · Cited by 2,051
TIGAR, a p53-Inducible Regulator of Glycolysis and Apoptosis
Bensaad, K., Tsuruta, A., Selak, M. A., Vidal, M. N. C., Nakano, K., Bartrons, R., Gottlieb, E., & Vousden, K. H. (2006) · Cell · doi:10.1016/j.cell.2006.05.036 · Cited by 2,019 · cited 2×
“p53 induces TIGAR expression and suppresses PFKFB3 expression in response to DNA damage, which in turn switches glycolysis to the PPP and thus promotes nucleotide synthesis to facilitate DNA repair in cells (Bensaad et al., 2006; Franklin et al., 2016).”
BackgroundThe first 30 years of p53: growing ever more complex.
Levine, A. J., & Oren, M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2723 · Cited by 1,967
Li, Y., Xu, S., Mihaylova, M. M., Zheng, B., Hou, X., Jiang, B., Park, O., Luo, Z., Lefai, E., Shyy, J. Y.-J., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.03.009 · Cited by 1,778
Functional genomics reveal that the serine synthesis pathway is essential in breast cancer
Possemato, R., Marks, K. M., Shaul, Y. D., Pacold, M. E., Kim, D., Birsoy, K., Sethumadhavan, S., Woo, H.-K., Jang, H. G., Jha, A. K., et al. (2011) · Nature · doi:10.1038/nature10350 · Cited by 1,683
The multifaceted roles of fatty acid synthesis in cancer
Röhrig, F., & Schulze, A. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.89 · Cited by 1,651
p53 Regulates Mitochondrial Respiration
Matoba, S., Kang, J.-G., Patino, W. D., Wragg, A., Boehm, M., Gavrilova, O., Hurley, P. J., Bunz, F., & Hwang, P. M. (2006) · Science · doi:10.1126/science.1126863 · Cited by 1,650
Muller, P. A. J., & Vousden, K. H. (2013) · Nature Cell Biology · doi:10.1038/ncb2641 · Cited by 1,647
HIF-1: upstream and downstream of cancer metabolism
Semenza, G. L. (2010) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2009.10.009 · Cited by 1,372
p53 Target Genes Sestrin1 and Sestrin2 Connect Genotoxic Stress and mTOR Signaling
Budanov, A. V., & Karin, M. (2008) · Cell · doi:10.1016/j.cell.2008.06.028 · Cited by 1,326 · cited 1×
“p53 was also reported to transcriptionally induce Sestrin 1/2 to activate AMPK, which negatively regulates mTORC1 activity, leading to the inhibition of glycolysis in cells (Budanov and Karin, 2008).”
BackgroundMutant p53 gain of function in two mouse models of Li-Fraumeni syndrome
Olive, K. P., Tuveson, D. A., Ruhe, Z. C., Yin, B., Willis, N. A., Bronson, R. T., Crowley, D., & Jacks, T. (2004) · Cell · doi:10.1016/j.cell.2004.11.004 · Cited by 1,308
MDM2, MDMX and p53 in oncogenesis and cancer therapy
Wade, M., Li, Y.-C., & Wahl, G. M. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3430 · Cited by 1,279 · cited 5×
“To maintain its proper function in tumor suppression, p53 is tightly regulated through different mechanisms in cells, including ubiquitination and degradation of p53 by different E3 ubiquitin ligases such as MDM2 (Vousden and Prives, 2009; Wade et al., 2013; Zhao et al., 2014; Tavana and Gu, 2017; Zhou et al., 2017).”
BackgroundInfluentialThe codon 72 polymorphic variants of p53 have markedly different apoptotic potential
Dumont, P., Leu, J. I.-J., Della Pietra, A. C., George, D. L., & Murphy, M. (2003) · Nature Genetics · doi:10.1038/ng1093 · Cited by 1,273
Mutant p53: one name, many proteins
Freed-Pastor, W. A., & Prives, C. (2012) · Genes & Development · doi:10.1101/gad.190678.112 · Cited by 1,247
The coordinate regulation of the p53 and mTOR pathways in cells
Feng, Z., Zhang, H., Levine, A. J., & Jin, S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502857102 · Cited by 1,235
Self-citationATP citrate lyase inhibition can suppress tumor cell growth
Hatzivassiliou, G., Zhao, F., Bauer, D. E., Andreadis, C., Shaw, A. N., Dhanak, D., Hingorani, S. R., Tuveson, D. A., & Thompson, C. B. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.09.008 · Cited by 1,086
P53 in survival, death and metabolic health: a lifeguard with a licence to kill.
Kruiswijk, F., Labuschagne, C. F., & Vousden, K. H. (2015) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm4007 · Cited by 1,080
Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome
Lang, G. A., Iwakuma, T., Suh, Y.-A., Liu, G., Rao, V. A., Parant, J. M., Valentin-Vega, Y. A., Terzian, T., Caldwell, L. C., Strong, L. C., et al. (2004) · Cell · doi:10.1016/j.cell.2004.11.006 · Cited by 1,069
Serine and glycine metabolism in cancer
Amelio, I., Cutruzzolá, F., Antonov, A., Agostini, M., & Melino, G. (2014) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2014.02.004 · Cited by 1,056
Targeting the PI3K pathway in cancer: are we making headway?
Janku, F., Yap, T. A., & Meric-Bernstam, F. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2018.28 · Cited by 1,033
Serine starvation induces stress and p53-dependent metabolic remodelling in cancer cells
Maddocks, O. D. K., Berkers, C. R., Mason, S. M., Zheng, L., Blyth, K., Gottlieb, E., & Vousden, K. H. (2013) · Nature · doi:10.1038/nature11743 · Cited by 1,007
Regulation of mammalian nucleotide metabolism and biosynthesis
Lane, A. N., & Fan, T. W.-M. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv047 · Cited by 959
The Tumor Suppressor p53 Limits Ferroptosis by Blocking DPP4 Activity
Xie, Y., Zhu, S., Song, X., Sun, X., Fan, Y., Liu, J., Zhong, M., Yuan, H., Zhang, L., Billiar, T. R., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.07.055 · Cited by 952
Self-citationRegulation of PTEN Transcription by p53
Stambolic, V., MacPherson, D., Sas, D., Lin, Y., Snow, B., Jang, Y., Benchimol, S., & Mak, T. W. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00323-9 · Cited by 912
Tumor Suppression in the Absence of p53-Mediated Cell-Cycle Arrest, Apoptosis, and Senescence
Li, T., Kon, N., Jiang, L., Tan, M., Ludwig, T., Zhao, Y., Baer, R., & Gu, W. (2012) · Cell · doi:10.1016/j.cell.2012.04.026 · Cited by 912
Mutant p53 disrupts mammary tissue architecture via the mevalonate pathway
Freed-Pastor, W. A., Mizuno, H., Zhao, X., Langerød, A., Moon, S.-H., Rodriguez-Barrueco, R., Barsotti, A., Chicas, A., Li, W., Polotskaia, A., et al. (2012) · Cell · doi:10.1016/j.cell.2011.12.017 · Cited by 865
Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function
Hu, W., Zhang, C., Wu, R., Sun, Y., Levine, A., & Feng, Z. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1001006107 · Cited by 862
Self-citationp53 regulates biosynthesis through direct inactivation of glucose-6-phosphate dehydrogenase
Jiang, P., Du, W., Wang, X., Mancuso, A., Gao, X., Wu, M., & Yang, X. (2011) · Nature Cell Biology · doi:10.1038/ncb2172 · Cited by 795
Activation of SAT1 engages polyamine metabolism with p53-mediated ferroptotic responses
Ou, Y., Wang, S.-J., Li, D., Chu, B., & Gu, W. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1607152113 · Cited by 765
The Tumor Suppressor p53 Down-Regulates Glucose Transporters GLUT1 and GLUT4 Gene Expression
Schwartzenberg-Bar-Yoseph, F., Armoni, M., & Karnieli, E. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-0846 · Cited by 726
Suzuki, S., Tanaka, T., Poyurovsky, M. V., Nagano, H., Mayama, T., Ohkubo, S., Lokshin, M., Hosokawa, H., Nakayama, T., Suzuki, Y., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002459107 · Cited by 705
The P53 pathway: what questions remain to be explored?
Levine, A. J., Hu, W., & Feng, Z. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401910 · Cited by 659
Self-citationGlycolytic Enzymes Can Modulate Cellular Life Span
Kondoh, H., Lleonart, M. E., Gil, J., Wang, J., Degan, P., Peters, G., Martinez, D., Carnero, A., & Beach, D. (2005) · Cancer Research · doi:10.1158/0008-5472.177.65.1 · Cited by 647 · cited 1×
“, 2014) and downregulates protein levels of phosphoglycerate mutase 1 (PGAM1) via an unclear mechanism, leading to the suppression of glycolysis (Kondoh et al., 2005).”
Backgroundp53 regulates glucose metabolism through an IKK-NF-κB pathway and inhibits cell transformation
Kawauchi, K., Araki, K., Tobiume, K., & Tanaka, N. (2008) · Nature Cell Biology · doi:10.1038/ncb1724 · Cited by 637
Feng, Z., Hu, W., de Stanchina, E., Teresky, A. K., Jin, S., Lowe, S., & Levine, A. J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4149 · Cited by 633
Self-citationRegulation of fatty acid synthesis and oxidation by the AMP-activated protein kinase
Hardie, D. G., & Pan, D. A. (2002) · Biochemical Society Transactions · doi:10.1042/bst0301064 · Cited by 559
p53 Suppresses Metabolic Stress-Induced Ferroptosis in Cancer Cells
Tarangelo, A., Magtanong, L., Bieging-Rolett, K. T., Li, Y., Ye, J., Attardi, L. D., & Dixon, S. J. (2018) · Cell Reports · doi:10.1016/j.celrep.2017.12.077 · Cited by 554
ATP citrate lyase is an important component of cell growth and transformation
Bauer, D. E., Hatzivassiliou, G., Zhao, F., Andreadis, C., & Thompson, C. B. (2005) · Oncogene · doi:10.1038/sj.onc.1208773 · Cited by 537
p53 regulates maternal reproduction through LIF
Hu, W., Feng, Z., Teresky, A. K., & Levine, A. J. (2007) · Nature · doi:10.1038/nature05993 · Cited by 445
Self-citationTumour-associated mutant p53 drives the Warburg effect
Zhang, C., Liu, J., Liang, Y., Wu, R., Zhao, Y., Hong, X., Lin, M., Yu, H., Liu, L., Levine, A. J., et al. (2013) · Nature Communications · doi:10.1038/ncomms3935 · Cited by 434
Self-citationParkin, a p53 target gene, mediates the role of p53 in glucose metabolism and the Warburg effect
Zhang, C., Lin, M., Wu, R., Wang, X., Yang, B., Levine, A. J., Hu, W., & Feng, Z. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1113884108 · Cited by 431
Self-citationHwang, P. M., Bunz, F., Yu, J., Rago, C., Chan, T. A., Murphy, M. P., Kelso, G. F., Smith, R. A. J., Kinzler, K. W., & Vogelstein, B. (2001) · Nature Medicine · doi:10.1038/nm1001-1111 · Cited by 422
The importance of serine metabolism in cancer
Mattaini, K. R., Sullivan, M. R., & Vander Heiden, M. G. (2016) · Journal of Cell Biology · doi:10.1083/jcb.201604085 · Cited by 410
The regulation of energy metabolism and the IGF-1/mTOR pathways by the p53 protein
Feng, Z., & Levine, A. J. (2010) · Trends in Cell Biology · doi:10.1016/j.tcb.2010.03.004 · Cited by 359
Self-citationIron Homeostasis in Health and Disease
Gozzelino, R., & Arosio, P. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17010130 · Cited by 359
The inherent instability of mutant p53 is alleviated by Mdm2 or p16 INK4a loss
Terzian, T., Suh, Y.-A., Iwakuma, T., Post, S. M., Neumann, M., Lang, G. A., Van Pelt, C. S., & Lozano, G. (2008) · Genes & Development · doi:10.1101/gad.1662908 · Cited by 357
Jennis, M., Kung, C.-P., Basu, S., Budina-Kolomets, A., Leu, J. I.-J., Khaku, S., Scott, J. P., Cai, K. Q., Campbell, M. R., Porter, D. K., et al. (2016) · Genes & Development · doi:10.1101/gad.275891.115 · Cited by 352
Iron and Cancer Risk—A Systematic Review and Meta-analysis of the Epidemiological Evidence
Fonseca-Nunes, A., Jakszyn, P., & Agudo, A. (2014) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-0733 · Cited by 350
Mullarky, E., Lucki, N. C., Beheshti Zavareh, R., Anglin, J. L., Gomes, A. P., Nicolay, B. N., Wong, J. C. Y., Christen, S., Takahashi, H., Singh, P. K., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1521548113 · Cited by 333
Coordination and communication between the p53 and IGF-1–AKT–TOR signal transduction pathways
Levine, A. J., Feng, Z., Mak, T. W., You, H., & Jin, S. (2006) · Genes & Development · doi:10.1101/gad.1363206 · Cited by 321
Self-citationMutant p53 in Cancer: Accumulation, Gain-of-Function, and Therapy
Yue, X., Zhao, Y., Xu, Y., Zheng, M., Feng, Z., & Hu, W. (2017) · Journal of Molecular Biology · doi:10.1016/j.jmb.2017.03.030 · Cited by 308
Self-citationValente, L. J., Gray, D. H. D., Michalak, E. M., Pinon-Hofbauer, J., Egle, A., Scott, C. L., Janic, A., & Strasser, A. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.04.012 · Cited by 291
Wang, L., Xiong, H., Wu, F., Zhang, Y., Wang, J., Zhao, L., Guo, X., Chang, L.-J., Zhang, Y., You, M. J., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.07.053 · Cited by 288
Two hot spot mutant p53 mouse models display differential gain of function in tumorigenesis
Hanel, W., Marchenko, N., Xu, S., Xiaofeng Yu, S., Weng, W., & Moll, U. (2013) · Cell Death & Differentiation · doi:10.1038/cdd.2013.17 · Cited by 283
Cancer risk in patients with hereditary hemochromatosis and in their first-degree relatives
Elmberg, M., Hultcrantz, R., Ekbom, A., Brandt, L., Olsson, S., Olsson, R., Lindgren, S., Lööf, L., Stål, P., Wallerstedt, S., et al. (2003) · Gastroenterology · doi:10.1053/j.gastro.2003.09.035 · Cited by 273
Tumor suppressor p53 and its mutants in cancer metabolism
Liu, J., Zhang, C., Hu, W., & Feng, Z. (2015) · Cancer Letters · doi:10.1016/j.canlet.2013.12.025 · Cited by 271
Self-citationThe p53 family: guardians of maternal reproduction
Levine, A. J., Tomasini, R., McKeon, F. D., Mak, T. W., & Melino, G. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3086 · Cited by 252
p53 Negatively Regulates Transcription of the Pyruvate Dehydrogenase Kinase Pdk2
Contractor, T., & Harris, C. R. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-1215 · Cited by 245
TP53 mutation spectra and load: a tool for generating hypotheses on the etiology of cancer.
Olivier, M., Hussain, S. P., de Fromentel, C. C., Hainaut, P. L., & Harris, C. C. (2004) · PubMed · Cited by 243
DNAJA1 controls the fate of misfolded mutant p53 through the mevalonate pathway
Parrales, A., Ranjan, A., Iyer, S. V., Padhye, S., Weir, S. J., Roy, A., & Iwakuma, T. (2016) · Nature Cell Biology · doi:10.1038/ncb3427 · Cited by 239
p53 Regulation of the IGF-1/AKT/mTOR Pathways and the Endosomal Compartment
Feng, Z. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a001057 · Cited by 237
Self-citationZhou, G., Wang, J., Zhao, M., Xie, T.-X., Tanaka, N., Sano, D., Patel, A. A., Ward, A. M., Sandulache, V. C., Jasser, S. A., et al. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.04.024 · Cited by 235
Glucose Catabolism in Cancer Cells
Mathupala, S. P., Heese, C., & Pedersen, P. L. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.36.22776 · Cited by 231
p53 Activation in Adipocytes of Obese Mice
Yahagi, N., Shimano, H., Matsuzaka, T., Najima, Y., Sekiya, M., Nakagawa, Y., Ide, T., Tomita, S., Okazaki, H., Tamura, Y., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302364200 · Cited by 220
Lawen, A., & Lane, D. J. R. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4271 · Cited by 217
Shen, J., Sheng, X., Chang, Z., Wu, Q., Wang, S., Xuan, Z., Li, D., Wu, Y., Shang, Y., Kong, X., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.02.042 · Cited by 213
Parkin targets HIF-1α for ubiquitination and degradation to inhibit breast tumor progression
Liu, J., Zhang, C., Zhao, Y., Yue, X., Wu, H., Huang, S., Chen, J., Tomsky, K., Xie, H., Khella, C. A., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01947-w · Cited by 213
Self-citationBoidot, R., Végran, F., Meulle, A., Le Breton, A., Dessy, C., Sonveaux, P., Lizard-Nacol, S., & Feron, O. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2474 · Cited by 203
Regulation of AIF expression by p53
Stambolsky, P., Weisz, L., Shats, I., Klein, Y., Goldfinger, N., Oren, M., & Rotter, V (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401965 · Cited by 194
ROS-Mediated p53 Induction of Lpin1 Regulates Fatty Acid Oxidation in Response to Nutritional Stress
Assaily, W., Rubinger, D. A., Wheaton, K., Lin, Y., Ma, W., Xuan, W., Brown-Endres, L., Tsuchihara, K., Mak, T. W., & Benchimol, S. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.08.038 · Cited by 192
The role of the p53 tumor suppressor in metabolism and diabetes
Kung, C.-P., & Murphy, M. E. (2016) · Journal of Endocrinology · doi:10.1530/joe-16-0324 · Cited by 178
The p53 Tumor Suppressor in the Control of Metabolism and Ferroptosis
Gnanapradeepan, K., Basu, S., Barnoud, T., Budina-Kolomets, A., Kung, C.-P., & Murphy, M. E. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00124 · Cited by 178
The regulation of MDM2 oncogene and its impact on human cancers
Zhao, Y., Yu, H., & Hu, W. (2014) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmt147 · Cited by 173
Self-citationNucleotide metabolism, oncogene-induced senescence and cancer
Aird, K. M., & Zhang, R. (2015) · Cancer Letters · doi:10.1016/j.canlet.2014.01.017 · Cited by 166
Ou, Y., Wang, S.-J., Jiang, L., Zheng, B., & Gu, W. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.616359 · Cited by 161
Tumor suppressor p53 and its gain-of-function mutants in cancer
Liu, J., Zhang, C., & Feng, Z. (2013) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmt144 · Cited by 154
Self-citationExploiting Metabolic Vulnerabilities of Cancer with Precision and Accuracy
Wolpaw, A. J., & Dang, C. V. (2017) · Trends in Cell Biology · doi:10.1016/j.tcb.2017.11.006 · Cited by 154
Ferredoxin reductase is critical for p53-dependent tumor suppression via iron regulatory protein 2Preprint
Zhang, Y., Qian, Y., Zhang, J., Yan, W., Jung, Y.-S., Chen, M., Huang, E. C., Lloyd, K. C. K., Duan, Y., Wang, J., et al. (2017) · Genes & Development · doi:10.1101/gad.299388.117 · Cited by 153
Zhang, C., Liu, J., Huang, G., Zhao, Y., Yue, X., Wu, H., Li, J., Zhu, J., Shen, Z., Haffty, B. G., et al. (2016) · Genes & Development · doi:10.1101/gad.283283.116 · Cited by 145
Self-citationPARK2 Depletion Connects Energy and Oxidative Stress to PI3K/Akt Activation via PTEN S-Nitrosylation
Gupta, A., Anjomani‐Virmouni, S., Koundouros, N., Dimitriadi, M., Choo-Wing, R., Valle, A., Zheng, Y., Chiu, Y., Agnihotri, S., Zadeh, G. M., et al. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.02.019 · Cited by 138
Role of p53 in Neurodegenerative Diseases
Chang, J. R., Ghafouri, M., Mukerjee, R., Bagashev, A., Chabrashvili, T., & Sawaya, B. E. (2012) · Neurodegenerative Diseases · doi:10.1159/000329999 · Cited by 134
The Codon 47 Polymorphism in p53 Is Functionally Significant
Li, X., Dumont, P., Pietra, A. D., Shetler, C. M., & Murphy, M. E. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414637200 · Cited by 134
Regulation of nucleotide metabolism by mutant p53 contributes to its gain-of-function activities
Kollareddy, M., Dimitrova, E., Vallabhaneni, K. C., Chan, A., Le, T., Chauhan, K. M., Carrero, Z. I., Ramakrishnan, G., Watabe, K., Haupt, Y., et al. (2015) · Nature Communications · doi:10.1038/ncomms8389 · Cited by 127
Liao, P., Zeng, S. X., Zhou, X. Y., Chen, T., Zhou, F., Cao, B., Jung, J. H., Sal, G. D., Luo, S., & Lu, H. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.11.006 · Cited by 123
Spliced MDM2 isoforms promote mutant p53 accumulation and gain-of-function in tumorigenesis
Zheng, T., Wang, J., Zhao, Y., Zhang, C., Lin, M., Wang, X., Yu, H., Liu, L., Feng, Z., & Hu, W. (2013) · Nature Communications · doi:10.1038/ncomms3996 · Cited by 116
Self-citationRegulation of iron homeostasis by the p53-ISCU pathway
Funauchi, Y., Tanikawa, C., Lo, P. H. Y., Mori, J., Daigo, Y., Takano, A., Miyagi, Y., Okawa, A., Nakamura, Y., & Matsuda, K. (2015) · Scientific Reports · doi:10.1038/srep16497 · Cited by 115
Modulation of the p53/MDM2 interplay by HAUSP inhibitors
Tavana, O., & Gu, W. J. (2016) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjw049 · Cited by 115
The Role of p53 Gene Family in Reproduction
Hu, W. (2009) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a001073 · Cited by 113
Self-citationTumor suppressor p53 negatively regulates glycolysis stimulated by hypoxia through its target RRAD
Zhang, C., Liu, J., Wu, R., Liang, Y., 林美华, Liu, J., Chan, C. S., Hu, W., & Feng, Z. (2014) · Oncotarget · doi:10.18632/oncotarget.2137 · Cited by 108
Self-citationHepcidin, a key regulator of iron metabolism, is transcriptionally activated by p53
Weizer‐Stern, O., Adamsky, K., Margalit, O., Ashur‐Fabian, O., Givol, D., Amariglio, N., & Rechavi, G. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06638.x · Cited by 108
p53 in neurodegenerative diseases and brain cancers
Checler, F., & da Costa, C. A. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.11.009 · Cited by 103
Hitting cancers’ weak spots: vulnerabilities imposed by p53 mutation
Gurpinar, E., & Vousden, K. H. (2015) · Trends in Cell Biology · doi:10.1016/j.tcb.2015.04.001 · Cited by 102
Liu, J., Zhang, C., Lin, M., Zhu, W. J., Liang, Y., Hong, X., Zhao, Y., Young, K. H., Hu, W., & Feng, Z. (2014) · Oncotarget · doi:10.18632/oncotarget.1862 · Cited by 99
Self-citationFranklin, D. A., He, Y. J., Leslie, P. L., Tikunov, A. P., Fenger, N., Macdonald, J. M., & Zhang, Y. (2016) · Scientific Reports · doi:10.1038/srep38067 · Cited by 99
Sanchez-Macedo, N., Feng, J., Faubert, B., Chang, N., Elia, A., Rushing, E. J., Tsuchihara, K., Bungard, D., Berger, S. L., Jones, R. G., et al. (2013) · Cell Death & Differentiation · doi:10.1038/cdd.2012.168 · Cited by 98
BAG2 promotes tumorigenesis through enhancing mutant p53 protein levels and function
Yue, X., Zhao, Y., Liu, J., Zhang, C., Yu, H., Wang, J., Zheng, T., Liu, L., Li, J., Feng, Z., et al. (2015) · eLife · doi:10.7554/elife.08401 · Cited by 88
Self-citation6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells
Ros, S., Flöter, J., Kaymak, I., Da Costa, C., Houddane, A., Dubuis, S., Griffiths, B., Mitter, R., Walz, S., Blake, S., et al. (2017) · Oncogene · doi:10.1038/onc.2016.477 · Cited by 83
Liu, Y., He, Y., Jin, A., Tikunov, A. P., Zhou, L., Tollini, L. A., Leslie, P., Kim, T.-H., Li, L. O., Coleman, R. A., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1315605111 · Cited by 80
Genetic Modifiers of the p53 Pathway
Basu, S., & Murphy, M. E. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026302 · Cited by 76
Viotti, J., Duplan, E., Caillava, C., Condat, J., Goiran, T., Giordano, C., Marie, Y., Idbaih, A., Delattre, J.-Y., Honnorat, J., et al. (2014) · Oncogene · doi:10.1038/onc.2013.124 · Cited by 65
Mutant p53 and mTOR/PKM2 regulation in cancer cells
Dando, I., Cordani, M., & Donadelli, M. (2016) · IUBMB Life · doi:10.1002/iub.1534 · Cited by 57
A polymorphism in the tumor suppressor p53 affects aging and longevity in mouse models
Zhao, Y., Wu, L., Yue, X., Zhang, C., Wang, J., Li, J., Sun, X., Zhu, Y., Feng, Z., & Hu, W. (2018) · eLife · doi:10.7554/elife.34701 · Cited by 57
Self-citationLink, P. A., Baer, M. R., James, S. R., Jones, D. A., & Karpf, A. R. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1860 · Cited by 53
P53 suppresses ribonucleotide reductase via inhibiting mTORC1
He, Z., Hu, X., Liu, W., Dorrance, A. M., Garzon, R., Houghton, P. J., & Shen, C. (2017) · Oncotarget · doi:10.18632/oncotarget.17440 · Cited by 43
Proteomic Analysis Reveals GMP Synthetase as p53 Repression Target in Liver Cancer
Hölzer, K., Drucker, E., Roessler, S. K., Dauch, D., Heinzmann, F., Waldburger, N., Eiteneuer, E. M., Herpel, E., Breuhahn, K., Zender, L., et al. (2016) · American Journal Of Pathology · doi:10.1016/j.ajpath.2016.09.022 · Cited by 42
Mdm proteins: critical regulators of embryogenesis and homoeostasis
Moyer, S. M., Larsson, C. A., & Lozano, G. (2017) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjx004 · Cited by 41
Negative auto-regulators trap p53 in their web
Zhou, X. Y., Cao, B., & Lu, H. (2017) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjx001 · Cited by 38
Parkinson's disease‐associated protein Parkin: an unusual player in cancer
Liu, J., Zhang, C., Hu, W., & Feng, Z. (2018) · Cancer Communications · doi:10.1186/s40880-018-0314-z · Cited by 37
Self-citationBlandino, G., Deppert, W., Hainaut, P., Levine, A., Lozano, G., Olivier, M., Rotter, V, Wiman, K., & Oren, M. (2012) · Cell Death & Differentiation · doi:10.1038/cdd.2011.148 · Cited by 34
Ferroptosis: A missing puzzle piece in the p53 blueprint?
Wang, S.-J., Ou, Y., Jiang, L., & Gu, W. J. (2015) · Molecular & Cellular Oncology · doi:10.1080/23723556.2015.1046581 · Cited by 25
Cited by
Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention
Butler, L. M., Perone, Y., Dehairs, J., Lupien, L. E., de Laat, V., Talebi, A., Loda, M., Kinlaw, W. B., & Swinnen, J. V. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.07.013 · Cited by 589
Lipid metabolic reprogramming in tumor microenvironment: from mechanisms to therapeutics
Jin, H.-R., Wang, J., Wang, Z.-J., Xi, M.-J., Xia, B.-H., Deng, K., & Yang, J.-L. (2023) · Journal of Hematology & Oncology · doi:10.1186/s13045-023-01498-2 · Cited by 481
Lacroix, M., Riscal, R., Arena, G., Linares, L. K., & Le Cam, L. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2019.10.002 · Cited by 373
Gain-of-function mutant p53 in cancer progression and therapy
Zhang, C., Liu, J., Xu, D., Zhang, T., Hu, W., & Feng, Z. (2020) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjaa040 · Cited by 334
Self-citationZhong, X., He, X., Wang, Y., Hu, Z., Huang, H., Zhao, S., Wei, P., & Li, D. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01358-5 · Cited by 329
Metadata
- Authors
- Liu, J., Zhang, C., Hu, W., & Feng, Z.
- Venue
- Journal of Molecular Cell Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-11-30
- Volume
- 11
- Issue
- 4
- Pages
- 284-292
- ISSN
- 1674-2788 (ISSN-L)
- 1759-4685
- OpenAlex
- W2902416164
- Cited by
- 300
- References
- 121
- FWCI
- 5.90
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.